COPD Drug Delivery Device Market Size - Global Industry, Share, Analysis, Trends and Forecast 2022 - 2030
CHAPTER 1. Industry Overview of COPD Drug Delivery Device Market
1.1. Definition and Scope
1.1.1. Definition of COPD Drug Delivery Device
1.1.2. Market Segmentation
1.1.3. Years Considered for the Study
1.1.4. Assumptions and Acronyms Used
1.1.4.1. Market Assumptions and Market Forecast
1.1.4.2. Acronyms Used in Global COPD Drug Delivery Device Market
1.2. Summary
1.2.1. Executive Summary
1.2.2. COPD Drug Delivery Device Market By Product
1.2.3. COPD Drug Delivery Device Market By Type
1.2.4. COPD Drug Delivery Device Market By Distribution Channel
1.2.5. COPD Drug Delivery Device Market By End-Use
1.2.6. COPD Drug Delivery Device Market By Region
CHAPTER 2. Research Approach
2.1. Methodology
2.1.1. Research Programs
2.1.2. Market Size Estimation
2.1.3. Market Breakdown and Data Triangulation
2.2. Data Source
2.2.1. Secondary Sources
2.2.2. Primary Sources
CHAPTER 3. Market Dynamics And Competition Analysis
3.1. Market Drivers
3.1.1. Driver 1
3.1.2. Driver 2
3.2. Restraints and Challenges
3.2.1. Restraint 1
3.2.2. Restraint 2
3.3. Growth Opportunities
3.3.1. Opportunity 1
3.3.2. Opportunity 2
3.4. Porter’s Five Forces Analysis
3.4.1. Bargaining Power of Suppliers
3.4.2. Bargaining Power of Buyers
3.4.3. Threat of Substitute
3.4.4. Threat of New Entrants
3.4.5. Degree of Competition
3.5. Market Concentration Ratio and Market Maturity Analysis of COPD Drug Delivery Device Market
3.5.1. Go To Market Strategy
3.5.1.1. Introduction
3.5.1.2. Growth
3.5.1.3. Maturity
3.5.1.4. Saturation
3.5.1.5. Possible Development
3.6. Technological Roadmap for COPD Drug Delivery Device Market
3.7. Value Chain Analysis
3.7.1. List of Key Manufacturers
3.7.2. List of Customers
3.7.3. Level of Integration
3.8. Cost Structure Analysis
3.8.1. Price Trend of Key Raw Materials
3.8.2. Raw Material Suppliers
3.8.3. Proportion of Manufacturing Cost Structure
3.8.3.1. Raw Material
3.8.3.2. Labor Cost
3.8.3.3. Manufacturing Expense
3.9. Regulatory Compliance
3.10. Competitive Landscape, 2021
3.10.1. Player Positioning Analysis
3.10.2. Key Strategies Adopted By Leading Players
CHAPTER 4. Manufacturing Plant Analysis
4.1. Manufacturing Plant Location and Establish Date of Major Manufacturers in 2021
4.2. R&D Status of Major Manufacturers in 2021
CHAPTER 5. COPD Drug Delivery Device Market By Product
5.1. Introduction
5.2. COPD Drug Delivery Device Revenue By Product
5.2.1. COPD Drug Delivery Device Revenue (USD Billion) and Forecast, By Product, 2018-2030
5.2.2. Nebulizers
5.2.2.1. Nebulizers Market Revenue (USD Billion) and Growth Rate (%), 2018-2030
5.2.3. Inhalers
5.2.3.1. Inhalers Market Revenue (USD Billion) and Growth Rate (%), 2018-2030
CHAPTER 6. COPD Drug Delivery Device Market By Type
6.1. Introduction
6.2. COPD Drug Delivery Device Revenue By Type
6.2.1. COPD Drug Delivery Device Revenue (USD Billion) and Forecast, By Type, 2018-2030
6.2.2. Manual Devices
6.2.2.1. Manual Devices Market Revenue (USD Billion) and Growth Rate (%), 2018-2030
6.2.3. Digital Devices
6.2.3.1. Digital Devices Market Revenue (USD Billion) and Growth Rate (%), 2018-2030
CHAPTER 7. COPD Drug Delivery Device Market By Distribution Channel
7.1. Introduction
7.2. COPD Drug Delivery Device Revenue By Distribution Channel
7.2.1. COPD Drug Delivery Device Revenue (USD Billion) and Forecast, By Distribution Channel, 2018-2030
7.2.2. Online
7.2.2.1. Online Market Revenue (USD Billion) and Growth Rate (%), 2018-2030
7.2.3. Offline
7.2.3.1. Offline Market Revenue (USD Billion) and Growth Rate (%), 2018-2030
CHAPTER 8. COPD Drug Delivery Device Market By End-Use
8.1. Introduction
8.2. COPD Drug Delivery Device Revenue By End-Use
8.2.1. COPD Drug Delivery Device Revenue (USD Billion) and Forecast, By End-Use, 2018-2030
8.2.2. Hospitals
8.2.2.1. Hospitals Market Revenue (USD Billion) and Growth Rate (%), 2018-2030
8.2.3. Clinics
8.2.3.1. Clinics Market Revenue (USD Billion) and Growth Rate (%), 2018-2030
8.2.4. Homecare Settings
8.2.4.1. Homecare Settings Market Revenue (USD Billion) and Growth Rate (%), 2018-2030
CHAPTER 9. North America COPD Drug Delivery Device Market By Country
9.1. North America COPD Drug Delivery Device Market Overview
9.2. U.S.
9.2.1. U.S. COPD Drug Delivery Device Revenue (USD Billion) and Forecast By Product, 2018-2030
9.2.2. U.S. COPD Drug Delivery Device Revenue (USD Billion) and Forecast By Type, 2018-2030
9.2.3. U.S. COPD Drug Delivery Device Revenue (USD Billion) and Forecast By Distribution Channel, 2018-2030
9.2.4. U.S. COPD Drug Delivery Device Revenue (USD Billion) and Forecast By End-Use, 2018-2030
9.3. Canada
9.3.1. Canada COPD Drug Delivery Device Revenue (USD Billion) and Forecast By Product, 2018-2030
9.3.2. Canada COPD Drug Delivery Device Revenue (USD Billion) and Forecast By Type, 2018-2030
9.3.3. Canada COPD Drug Delivery Device Revenue (USD Billion) and Forecast By Distribution Channel, 2018-2030
9.3.4. Canada COPD Drug Delivery Device Revenue (USD Billion) and Forecast By End-Use, 2018-2030
9.4. North America PEST Analysis
CHAPTER 10. Europe COPD Drug Delivery Device Market By Country
10.1. Europe COPD Drug Delivery Device Market Overview
10.2. U.K.
10.2.1. U.K. COPD Drug Delivery Device Revenue (USD Billion) and Forecast By Product, 2018-2030
10.2.2. U.K. COPD Drug Delivery Device Revenue (USD Billion) and Forecast By Type, 2018-2030
10.2.3. U.K. COPD Drug Delivery Device Revenue (USD Billion) and Forecast By Distribution Channel, 2018-2030
10.2.4. U.K. COPD Drug Delivery Device Revenue (USD Billion) and Forecast By End-Use, 2018-2030
10.3. Germany
10.3.1. Germany COPD Drug Delivery Device Revenue (USD Billion) and Forecast By Product, 2018-2030
10.3.2. Germany COPD Drug Delivery Device Revenue (USD Billion) and Forecast By Type, 2018-2030
10.3.3. Germany COPD Drug Delivery Device Revenue (USD Billion) and Forecast By Distribution Channel, 2018-2030
10.3.4. Germany COPD Drug Delivery Device Revenue (USD Billion) and Forecast By End-Use, 2018-2030
10.4. France
10.4.1. France COPD Drug Delivery Device Revenue (USD Billion) and Forecast By Product, 2018-2030
10.4.2. France COPD Drug Delivery Device Revenue (USD Billion) and Forecast By Type, 2018-2030
10.4.3. France COPD Drug Delivery Device Revenue (USD Billion) and Forecast By Distribution Channel, 2018-2030
10.4.4. France COPD Drug Delivery Device Revenue (USD Billion) and Forecast By End-Use, 2018-2030
10.5. Spain
10.5.1. Spain COPD Drug Delivery Device Revenue (USD Billion) and Forecast By Product, 2018-2030
10.5.2. Spain COPD Drug Delivery Device Revenue (USD Billion) and Forecast By Type, 2018-2030
10.5.3. Spain COPD Drug Delivery Device Revenue (USD Billion) and Forecast By Distribution Channel, 2018-2030
10.5.4. Spain COPD Drug Delivery Device Revenue (USD Billion) and Forecast By End-Use, 2018-2030
10.6. Rest of Europe
10.6.1. Rest of Europe COPD Drug Delivery Device Revenue (USD Billion) and Forecast By Product, 2018-2030
10.6.2. Rest of Europe COPD Drug Delivery Device Revenue (USD Billion) and Forecast By Type, 2018-2030
10.6.3. Rest of Europe COPD Drug Delivery Device Revenue (USD Billion) and Forecast By Distribution Channel, 2018-2030
10.6.4. Rest of Europe COPD Drug Delivery Device Revenue (USD Billion) and Forecast By End-Use, 2018-2030
10.7. Europe PEST Analysis
CHAPTER 11. Asia Pacific COPD Drug Delivery Device Market By Country
11.1. Asia Pacific COPD Drug Delivery Device Market Overview
11.2. China
11.2.1. China COPD Drug Delivery Device Revenue (USD Billion) and Forecast By Product, 2018-2030
11.2.2. China COPD Drug Delivery Device Revenue (USD Billion) and Forecast By Type, 2018-2030
11.2.3. China COPD Drug Delivery Device Revenue (USD Billion) and Forecast By Distribution Channel, 2018-2030
11.2.4. China COPD Drug Delivery Device Revenue (USD Billion) and Forecast By End-Use, 2018-2030
11.3. Japan
11.3.1. Japan COPD Drug Delivery Device Revenue (USD Billion) and Forecast By Product, 2018-2030
11.3.2. Japan COPD Drug Delivery Device Revenue (USD Billion) and Forecast By Type, 2018-2030
11.3.3. Japan COPD Drug Delivery Device Revenue (USD Billion) and Forecast By Distribution Channel, 2018-2030
11.3.4. Japan COPD Drug Delivery Device Revenue (USD Billion) and Forecast By End-Use, 2018-2030
11.4. India
11.4.1. India COPD Drug Delivery Device Revenue (USD Billion) and Forecast By Product, 2018-2030
11.4.2. India COPD Drug Delivery Device Revenue (USD Billion) and Forecast By Type, 2018-2030
11.4.3. India COPD Drug Delivery Device Revenue (USD Billion) and Forecast By Distribution Channel, 2018-2030
11.4.4. India COPD Drug Delivery Device Revenue (USD Billion) and Forecast By End-Use, 2018-2030
11.5. Australia
11.5.1. Australia COPD Drug Delivery Device Revenue (USD Billion) and Forecast By Product, 2018-2030
11.5.2. Australia COPD Drug Delivery Device Revenue (USD Billion) and Forecast By Type, 2018-2030
11.5.3. Australia COPD Drug Delivery Device Revenue (USD Billion) and Forecast By Distribution Channel, 2018-2030
11.5.4. Australia COPD Drug Delivery Device Revenue (USD Billion) and Forecast By End-Use, 2018-2030
11.6. South Korea
11.6.1. South Korea COPD Drug Delivery Device Revenue (USD Billion) and Forecast By Product, 2018-2030
11.6.2. South Korea COPD Drug Delivery Device Revenue (USD Billion) and Forecast By Type, 2018-2030
11.6.3. South Korea COPD Drug Delivery Device Revenue (USD Billion) and Forecast By Distribution Channel, 2018-2030
11.6.4. South Korea COPD Drug Delivery Device Revenue (USD Billion) and Forecast By End-Use, 2018-2030
11.7. Rest of Asia-Pacific
11.7.1. Rest of Asia-Pacific COPD Drug Delivery Device Revenue (USD Billion) and Forecast By Product, 2018-2030
11.7.2. Rest of Asia-Pacific COPD Drug Delivery Device Revenue (USD Billion) and Forecast By Type, 2018-2030
11.7.3. Rest of Asia-Pacific COPD Drug Delivery Device Revenue (USD Billion) and Forecast By Distribution Channel, 2018-2030
11.7.4. Rest of Asia-Pacific COPD Drug Delivery Device Revenue (USD Billion) and Forecast By End-Use, 2018-2030
11.8. Asia Pacific PEST Analysis
CHAPTER 12. Latin America COPD Drug Delivery Device Market By Country
12.1. Latin America COPD Drug Delivery Device Market Overview
12.2. Brazil
12.2.1. Brazil COPD Drug Delivery Device Revenue (USD Billion) and Forecast By Product, 2018-2030
12.2.2. Brazil COPD Drug Delivery Device Revenue (USD Billion) and Forecast By Type, 2018-2030
12.2.3. Brazil COPD Drug Delivery Device Revenue (USD Billion) and Forecast By Distribution Channel, 2018-2030
12.2.4. Brazil COPD Drug Delivery Device Revenue (USD Billion) and Forecast By End-Use, 2018-2030
12.3. Mexico
12.3.1. Mexico COPD Drug Delivery Device Revenue (USD Billion) and Forecast By Product, 2018-2030
12.3.2. Mexico COPD Drug Delivery Device Revenue (USD Billion) and Forecast By Type, 2018-2030
12.3.3. Mexico COPD Drug Delivery Device Revenue (USD Billion) and Forecast By Distribution Channel, 2018-2030
12.3.4. Mexico COPD Drug Delivery Device Revenue (USD Billion) and Forecast By End-Use, 2018-2030
12.4. Rest of Latin America
12.4.1. Rest of Latin America COPD Drug Delivery Device Revenue (USD Billion) and Forecast By Product, 2018-2030
12.4.2. Rest of Latin America COPD Drug Delivery Device Revenue (USD Billion) and Forecast By Type, 2018-2030
12.4.3. Rest of Latin America COPD Drug Delivery Device Revenue (USD Billion) and Forecast By Distribution Channel, 2018-2030
12.4.4. Rest of Latin America COPD Drug Delivery Device Revenue (USD Billion) and Forecast By End-Use, 2018-2030
12.5. Latin America PEST Analysis
CHAPTER 13. Middle East & Africa COPD Drug Delivery Device Market By Country
13.1. Middle East & Africa COPD Drug Delivery Device Market Overview
13.2. GCC
13.2.1. GCC COPD Drug Delivery Device Revenue (USD Billion) and Forecast By Product, 2018-2030
13.2.2. GCC COPD Drug Delivery Device Revenue (USD Billion) and Forecast By Type, 2018-2030
13.2.3. GCC COPD Drug Delivery Device Revenue (USD Billion) and Forecast By Distribution Channel, 2018-2030
13.2.4. GCC COPD Drug Delivery Device Revenue (USD Billion) and Forecast By End-Use, 2018-2030
13.3. South Africa
13.3.1. South Africa COPD Drug Delivery Device Revenue (USD Billion) and Forecast By Product, 2018-2030
13.3.2. South Africa COPD Drug Delivery Device Revenue (USD Billion) and Forecast By Type, 2018-2030
13.3.3. South Africa COPD Drug Delivery Device Revenue (USD Billion) and Forecast By Distribution Channel, 2018-2030
13.3.4. South Africa COPD Drug Delivery Device Revenue (USD Billion) and Forecast By End-Use, 2018-2030
13.4. Rest of Middle East & Africa
13.4.1. Rest of Middle East & Africa COPD Drug Delivery Device Revenue (USD Billion) and Forecast By Product, 2018-2030
13.4.2. Rest of Middle East & Africa COPD Drug Delivery Device Revenue (USD Billion) and Forecast By Type, 2018-2030
13.4.3. Rest of Middle East & Africa COPD Drug Delivery Device Revenue (USD Billion) and Forecast By Distribution Channel, 2018-2030
13.4.4. Rest of Middle East & Africa COPD Drug Delivery Device Revenue (USD Billion) and Forecast By End-Use, 2018-2030
13.5. Middle East & Africa PEST Analysis
CHAPTER 14. Player Analysis Of COPD Drug Delivery Device Market
14.1. COPD Drug Delivery Device Market Company Share Analysis
14.2. Competition Matrix
14.2.1. Competitive Benchmarking of key players by price, presence, market share, and R&D investment
14.2.2. New Product Launches and Product Enhancements
14.2.3. Mergers And Acquisition In Global COPD Drug Delivery Device Market
14.2.4. Partnership, Joint Ventures and Strategic Alliances/ Sales Agreements
CHAPTER 15. Company Profile
15.1. Boehringer Ingelheim GmbH
15.1.1. Company Snapshot
15.1.2. Business Overview
15.1.3. Financial Overview
15.1.3.1. Revenue (USD Billion), 2021
15.1.3.2. Boehringer Ingelheim GmbH 2021 COPD Drug Delivery Device Business Regional Distribution
15.1.4. Product /Service and Specification
15.1.5. Recent Developments & Business Strategy
15.2. GlaxoSmithKline plc
15.3. Novartis AG
15.4. Teva Pharmaceutical Industries
15.5. Merck & Co., Inc.
15.6. Cipla Inc.
15.7. Sunovion Pharmaceuticals, Inc.
15.8. Koninklijke Philips N.V.
15.9. AstraZeneca
15.10. PARI GmbH
15.11. Omron Corporation
Frequently Asked Questions
What is the size of global COPD Drug Delivery Device market in 2021?
The market size of COPD drug delivery device market in 2021 was accounted to be USD 9.2 Billion.
What is the CAGR of global COPD Drug Delivery Device market during forecast period of 2022 to 2030?
The projected CAGR of COPD drug delivery device market during the analysis period of 2022 to 2030 is 4.7%.
Which are the key players operating in the market?
The prominent players of the global COPD drug delivery device market are Boehringer Ingelheim GmbH, GlaxoSmithKline plc, Novartis AG, Teva Pharmaceutical Industries, Merck & Co., Inc., Cipla Inc., Sunovion Pharmaceuticals, Inc., Koninklijke Philips N.V., AstraZeneca, PARI GmbH, and Omron Corporation.
Which region held the dominating position in the global COPD Drug Delivery Device market?
North America held the dominating COPD drug delivery device during the analysis period of 2022 to 2030.
Which region registered the fastest growing CAGR for the forecast period of 2022 to 2030?
Asia-Pacific region exhibited fastest growing CAGR for COPD drug delivery device during the analysis period of 2022 to 2030.
What are the current trends and dynamics in the global COPD Drug Delivery Device market?
Increasing number of COPD population, rising incidences of chronic disorders, and surging base of elderly population drives the growth of global COPD drug delivery device market.
Which product held the maximum share in 2021?
Based on product, inhalers segment is expected to hold the maximum share COPD drug delivery device market.
Select Licence Type
Connect with our sales team
Why Acumen Research And Consulting
100%
Customer Satisfaction
24x7
Availability - we are always there when you need us
200+
Fortune 50 Companies trust Acumen Research and Consulting
80%
of our reports are exclusive and first in the industry
100%
more data and analysis
1000+
reports published till date
